This post is from a suggested group
Lyme Disease Diagnostic Market Growth: Evolving Detection Technologies and Expanding Awareness for Early Infection Manag
The Lyme Disease Diagnostic Market is gaining traction as Lyme disease continues to rise, particularly in North America and Europe. Caused by Borrelia burgdorferi and transmitted through tick bites, Lyme disease requires early and accurate diagnosis to prevent long-term complications.
Traditional serological tests are being complemented by advanced molecular diagnostics, including PCR-based assays and next-generation sequencing (NGS) methods. The surge in research on biomarker discovery and point-of-care testing has led to faster and more precise diagnostic outcomes. Additionally, public health initiatives focusing on tick-borne diseases have increased awareness and screening rates, propelling market demand. Diagnostic laboratories and biotech firms are expanding their portfolios to include improved ELISA and Western blot assays with enhanced sensitivity.
The future of the Lyme Disease Diagnostic Market lies in developing rapid, portable testing solutions that deliver results in real-time, even in remote or resource-limited regions. AI-powered diagnostic algorithms and integrated digital reporting platforms are improving clinical decision-making and…